BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31709263)

  • 21. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
    Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
    Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of long non-coding RNA
    Zhang X; Chi Q; Zhao Z
    Oncotarget; 2017 Aug; 8(31):51058-51065. PubMed ID: 28881629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
    Zhou Y; Wang DL; Pang Q
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer.
    Thiele JA; Hosek P; Kralovcova E; Ostasov P; Liska V; Bruha J; Vycital O; Rosendorf J; Opattova A; Horak J; Kralickova M; Vodicka P; Pitule P
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling.
    Zhu X; Liu Y; Yu J; Du J; Guo R; Feng Y; Zhong G; Jiang Y; Lin J
    Atherosclerosis; 2019 Feb; 281():38-46. PubMed ID: 30658190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
    Khaitan D; Dinger ME; Mazar J; Crawford J; Smith MA; Mattick JS; Perera RJ
    Cancer Res; 2011 Jun; 71(11):3852-62. PubMed ID: 21558391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
    Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
    Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
    Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
    Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lncRNA
    Gholami L; Ghafouri-Fard S; Mirzajani S; Arsang-Jang S; Taheri M; Dehbani Z; Dehghani S; Houshmand B; Amid R; Sayad A; Shams B
    Noncoding RNA Res; 2020 Jun; 5(2):60-66. PubMed ID: 32346660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma.
    Jing W; Gao S; Zhu M; Luo P; Jing X; Chai H; Tu J
    Oncol Rep; 2016 Aug; 36(2):1085-92. PubMed ID: 27278245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer.
    Li Q; Dai Y; Wang F; Hou S
    Neoplasma; 2016; 63(6):977-983. PubMed ID: 27596298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
    Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
    Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
    Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.